 Ryan Watts, President and CEO at Denali Therapeutics NASDAQ:DNLI, made a large insider sell on September 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Watts sold 18,333 shares of Denali Therapeutics at a price of 54.59 per share. 